TCP-1 peptide appears to be a promising agent in molecular imaging and drug delivery for human gastrointestinal cancers since preliminary data shows that it could also recognize the blood vessels in colorectal cancer samples in humans. This evidence concerns the gene TCP1 and colorectal cancer.